8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by 2030 with NSCLC Segment (8% CAGR) Driving Growth During 2022-2030 | The Insight Partners Pune, India, July 06, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Lung Cancer Screening Market Size Report and Forecast to 2030 - COVID-19 Impact and...

bioAffinity Technologies Announces Award of Canadian Patent SAN ANTONIO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, announced that the Canadian Intellectual Property Office has awarded a patent expanding the...

Study finds 43 percent of patients undergoing lung cancer screening experience elevated levels of distress GLENVIEW, Ill., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Low-dose computed tomography (LDCT) lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but...